Literature DB >> 25324667

Effective treatment of congenital melanocytic nevus and nevus sebaceous using the pinhole method with the erbium-doped yttrium aluminium garnet laser.

Bo Young Chung1, Seung Seog Han2, Byung Wook Kim3, Sung Eun Chang3, Mi Woo Lee3.   

Abstract

Entities:  

Year:  2014        PMID: 25324667      PMCID: PMC4198602          DOI: 10.5021/ad.2014.26.5.651

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


× No keyword cloud information.
Dear Editor: Congenital melanocytic nevus (CMN) is a melanocytic nevus that is either present at birth or appears during the latter stages of infancy1. Nevus sebaceous has been described as the hamartomatous locus of an embryologically defective pilosebaceous unit2. Here, we describe how we used the pinhole technique with an erbium-doped yttrium aluminium garnet (erbium : YAG) laser to treat nevi lesions in different patients. A 25-year-old male was diagnosed with CMN on his nose at birth (Fig. 1A). Emla cream (AstraZeneca AB, Sodertalje, Sweden) was applied to the treatment area prior to starting the procedure. The erbium : YAG laser (Action Er : YAG; Lutronic Corporation, Goyang, Korea) was used in continuous-wave mode, with 1-mm spot size and output power of 0.2 mJ/cm2. Multiple small holes measuring 1 mm in diameter were made on the periphery of the CMN lesion. A hydrocolloid dressing (DuoDERM Extra Thin CGF dressing; ConvaTec, ER Squibb & Sons, Princeton, NJ, USA) was applied to the lesions for ≥2 weeks after treatment. After performing 5 laser sessions at 4-week intervals, the cutaneous lesions resolved. There was no evidence of recurrence at the 1-year follow-up examination (Fig. 1B).
Fig. 1

Congenital melanocytic nevus (CMN) in a 25-year-old man. (A) Before treatment: a solitary, 1-cm brown patch is visible on the right alar area of the nose. (B) One year after the final treatment session, the skin lesions resolved with minimal scarring. (C) CMN in a 5-month-old boy. Before treatment, a solitary, 1.5~2-cm, well-demarcated, brown patch is visible on the forearm. (D) The pinhole method was used to create 1-mm holes deep in the dermis. (E) Minimal mottled hyperpigmentation was observed 6 months after the final laser treatment.

A 5-month-old infant was referred to our outpatient unit for CMN on the forearm (Fig. 1C). We performed the pinhole method of treatment using the erbium : YAG laser (Lutronic) in continuous-wave mode, with 1-mm spot size and output power of 0.2 mJ/cm2 (Fig. 1D). After receiving 6 treatment sessions at 2-month intervals, slight superficial pigmentation persisted (Fig. 1E). A 40-year-old woman presented with nevus sebaceous lesions on the right side of her forehead (Fig. 2A). We performed the pinhole method of treatment using the erbium : YAG laser (Lutronic) in continuous-wave mode, with 1-mm spot size and output power of 0.2 mJ/cm2. After receiving 5 treatment sessions at 4-week intervals, the patient showed marked improvement with only mild hypopigmentation (Fig. 2B). No recurrence was noted at the 6-month follow-up examination (Fig. 2C).
Fig. 2

Nevus sebaceous lesions in a 40-year-old woman. (A) Before treatment, two 2.5-cm, well-demarcated, yellow, verrucous plaques were visible on the right side of the forehead. (B) Deep line- and doughnut-shaped holes were created to remove the nevus sebaceus lesions. (C) Six months after the final laser treatment, the patient showed marked improvement, with only mild hypopigmentation.

Herein, we described how nevi lesions were effectively treated using the pinhole method. This simple method involves making multiple small holes at 2~5-mm intervals using a CO2 laser that penetrates the epidermis and deeper dermis3. The holes produced using the pinhole method are surrounded by untreated areas that promote rapid epidermal repair, thereby reducing the downtime and likelihood of side effects4. The other advantages of performing the pinhole method with ablative lasers are that this laser is easy to use and inexpensive, as ablative lasers are usually available in most dermatology clinics. To the best of our knowledge, this is the first report on the application of the pinhole method for the treatment of CMN and nevus sebaceous, so it is difficult to compare the advantages and disadvantages of the pinhole method with those of conventional treatment methods. Therefore, it is necessary to conduct further studies with a large sample to confirm the effectiveness and safety of the pinhole method. In conclusion, we suggest using the pinhole method with erbium : YAG laser as an alternative therapy for treating nevi lesions.
  2 in total

1.  Treatment of elastosis perforans serpiginosa with the pinhole method using a carbon dioxide laser.

Authors:  Ji Hye Yang; Seung Seog Han; Chong Hyun Won; Sung Eun Chang; Mi Woo Lee; Jee Ho Choi; Kee Chan Moon
Journal:  Dermatol Surg       Date:  2011-03-09       Impact factor: 3.398

2.  Burn scars treated by pinhole method using a carbon dioxide laser.

Authors:  Sung Won Whang; Kyu-Yeop Lee; Sung Bin Cho; Sang Joo Lee; Jin Moon Kang; Young Koo Kim; In Hwan Nam; Kee Yang Chung
Journal:  J Dermatol       Date:  2006-12       Impact factor: 4.005

  2 in total
  4 in total

1.  Donut Ablation Method as an Alternative to Surgical Excision or Total Ablational Laser Treatment.

Authors:  Joon Min Jung; Seung Seog Han; Chong Hyun Won; Sung Eun Chang
Journal:  Ann Dermatol       Date:  2016-07-26       Impact factor: 1.444

2.  Treatment of Nodular Fasciitis Occurring on the Face.

Authors:  Byung Ho Oh; Jihee Kim; Zhenlong Zheng; Mi Ryung Roh; Kee Yang Chung
Journal:  Ann Dermatol       Date:  2015-12-07       Impact factor: 1.444

3.  Skin Wound Tension Reduction Device Combined with Ablative Fractional Carbon Dioxide Laser to Reduce Scar Formation After Excision of Pediatric Facial Skin Lesions: A Prospective Cohort Study.

Authors:  Haiting Xu; Jing Li; Zifu Zhou; Jianhai Bi; Xiaoyang Li; Ran Huo
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-02-22

4.  Eccrine Poroma Arising within Nevus Sebaceous.

Authors:  Natnicha Girdwichai; Kumutnart Chanprapaph; Vasanop Vachiramon
Journal:  Case Rep Dermatol       Date:  2016-04-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.